Fluvastatin Versus Hepatitis C Virus

Bader, Ted, M.D.

Status: Completed

Conditions: Hepatitis C

Treatments: Drug: fluvastatin

Study type: Interventional

Funder types: Other U.S. Federal agency

Identifiers

NCT00441493

13134

13035

Details and patient eligibility

About

This is a dose finding and efficacy trial for fluvastatin versus hepatitis C.

Full description

Four different oral doses of fluvastatin will be used for 14 days and the viral load of hepatitis C will be measured weekly. This has been extended to different doses for 9-12 weeks.

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• HCV RNA positive

Exclusion criteria

• Testing positive for alcohol or marijuana

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)